A 52-year-old man is evaluated in the clinic for persistently elevated blood pressure. He … — USMLE Step 2 CK

A $52$ -year-old man is evaluated in the clinic for persistently elevated blood pressure. He is currently taking maximally tolerated doses of lisinopril, amlodipine, and hydrochlorothiazide. His blood pressure today is $168/94\text{ mmHg}$ , and his heart rate is $76\text{/min}$ . Laboratory studies reveal a serum potassium level of $3.0\text{ mEq/L}$ and a serum sodium level of $144\text{ mEq/L}$ . The patient's antihypertensive regimen is transitioned to non-interfering medications (e.g., verapamil and doxazosin), and his hypokalemia is corrected with oral potassium supplementation. The physician strongly suspects a specific endocrine etiology for his resistant hypertension and hypokalemia. Arrange the following diagnostic steps in the most appropriate chronological sequence to definitively evaluate and manage this patient's suspected condition.

1Measure early morning plasma aldosterone concentration and plasma renin activity
2Administer a two-liter intravenous normal saline infusion over four hours
3Obtain a high-resolution computed tomography scan of the adrenal glands
4Perform bilateral adrenal venous sampling

Answer

The correct sequence is to first screen with a plasma aldosterone-to-renin ratio, second confirm the diagnosis with an intravenous saline infusion test, third localize the pathology with an adrenal computed tomography scan, and finally lateralize the hypersecretion using bilateral adrenal venous sampling.

The evaluation of primary aldosteronism (Conn syndrome) strictly follows a three-phase diagnostic algorithm: screening, confirmation, and subtype classification. Initial screening is accomplished by calculating the ratio of plasma aldosterone concentration to plasma renin activity. If this ratio is elevated, the patient undergoes dynamic confirmatory testing, typically via an intravenous saline infusion test or an oral sodium load, to prove that aldosterone secretion is autonomous and non-suppressible. Once biochemically confirmed, subtype classification begins with an adrenal computed tomography (CT) scan to assess the anatomy. However, because non-functioning adrenal incidentalomas are very common in patients over 35 years of age, imaging alone is insufficient to prove that a visualized nodule is the source of hormone excess. Therefore, the final step before surgical adrenalectomy is bilateral adrenal venous sampling to functionally confirm the lateralization of aldosterone hypersecretion.

Step-by-Step Solution

Screen with plasma aldosterone concentration and plasma renin activity.

Identifies individuals at high risk for primary aldosteronism.

It is the most sensitive test to detect hyperaldosteronism in patients presenting with resistant hypertension and hypokalemia.

Confirm diagnosis with an intravenous saline infusion test.

Demonstrates inappropriate, autonomous aldosterone secretion that fails to suppress under a sodium load.

Biochemical confirmation is mandatory before pursuing invasive or expensive anatomical imaging, as false positives can occur with the screening ratio.

Assess anatomy with a high-resolution adrenal computed tomography scan.

Identifies macroscopic adrenal abnormalities such as unilateral nodules, bilateral hyperplasia, or large carcinomas.

Provides an anatomical map necessary to rule out malignancy and guide subsequent invasive lateralization procedures.

Perform bilateral adrenal venous sampling.

Compares aldosterone levels from both adrenal veins.

Because non-functioning adrenal incidentalomas are highly prevalent in patients older than 35, this step distinguishes an active aldosterone-producing adenoma from bilateral adrenal hyperplasia, which dictates whether the patient requires surgery or medical therapy.

Key Concept

Diagnostic algorithm for primary aldosteronism

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic